CAS 413611-93-5

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS: 413611-93-5

Formula: C₁₈H₁₂N₄O₃

Purity: 97%

Color and Shape: Solid

Molecular weight: 332.3129

Ref: IN-DA00C0XJ

10074-G5

CAS: 413611-93-5

10074-G5

Formula: C₁₈H₁₂N₄O₃

Purity: ≥95%

Molecular weight: 332.31

Ref: 54-BUP13086

10074-G5

CAS: 413611-93-5

Formula: C₁₈H₁₂N₄O₃

Molecular weight: 332.32

Ref: 4Z-K-031083

10074-G5

CAS: 413611-93-5

10074-G5 is an inhibitor of c-Myc-Max dimerization.

Formula: C₁₈H₁₂N₄O₃

Purity: 99.51% - 99.94%

Color and Shape: Red Solid

Molecular weight: 332.31

Ref: TM-T3686

10074-G5

CAS: 413611-93-5

Ref: BE-RMCK020081

10074-G5

CAS: 413611-93-5

N-([1,1'-Biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine

Formula: C₁₈H₁₂N₄O₃

Purity: 99%

Molecular weight: 332.31

Ref: IN-DG767022

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS: 413611-93-5

Purity: 97%

Molecular weight: 332.3190002

Ref: 10-F866494

c-Myc Inhibitor II

CAS: 413611-93-5

C-Myc Inhibitor II is a novel inhibitor of c-Myc transcriptional activity. It inhibits the proliferation of hematopoietic cells and has been shown to be effective in animal models of leukemia, lymphoma, and myeloma. C-Myc Inhibitor II also inhibits the growth of human tumor cells in culture. This drug inhibits the expression of genes related to cell cycle regulation, lipid metabolism, and DNA replication. C-Myc Inhibitor II binds to ATP levels, which may account for its ability to inhibit muscle cell proliferation.

Formula: C₁₈H₁₂N₄O₃

Purity: Min. 95%

Molecular weight: 332.31 g/mol

Ref: 3D-NRA61193